FXH vs. IDNA

Last updated Jun 4, 2026

FXH (First Trust Health Care AlphaDEX Fund) and IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) are both Health & Biotech Equities funds - FXH tracks the StrataQuant Health Care Index while IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index. Both are passively managed. Over the past 5 years, FXH returned 0.56%/yr vs -8.42%/yr for IDNA. A 0.73 correlation means they provide meaningful diversification when combined. FXH charges 0.61%/yr vs 0.47%/yr for IDNA.

Performance

FXH vs. IDNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Health Care AlphaDEX Fund (FXH) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FXH achieves a 0.68% return, which is significantly lower than IDNA's 10.31% return.

FXH

• 1D: 1.48%
• 1M: 1.65%
• YTD: 0.68%
• 6M: -0.88%
• 1Y: 13.28%
• 3Y*: 3.52%
• 5Y*: 0.56%
• 10Y*: 7.03%

IDNA

• 1D: 0.73%
• 1M: -2.56%
• YTD: 10.31%
• 6M: 8.52%
• 1Y: 40.87%
• 3Y*: 6.74%
• 5Y*: -8.42%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

FXH vs. IDNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
FXH First Trust Health Care AlphaDEX Fund	0.68%	10.16%	0.96%	-4.53%	-12.24%	15.20%	28.00%	11.79%
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund	10.31%	17.26%	-0.72%	-7.63%	-42.28%	-3.98%	54.30%	20.83%

Correlation

The correlation between FXH and IDNA is 0.68, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.68
Correlation (3Y) Calculated over the trailing 3-year period	0.69
Correlation (5Y) Calculated over the trailing 5-year period	0.72
Correlation (All Time) Calculated using the full available price history since Jun 14, 2019	0.73

The correlation between FXH and IDNA has been stable across timeframes, ranging from 0.68 to 0.73 - a consistent structural relationship.

FXH vs. IDNA - Sectors Allocation Comparison

Sectors	FXH	IDNA
Healthcare	100.0%	97.8%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	-
Industrials	-	0.4%
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

FXH vs. IDNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FXH

FXH Risk / Return Rank: 24
FXH Sharpe Ratio Rank: 24
FXH Sortino Ratio Rank: 24
FXH Omega Ratio Rank: 23
FXH Calmar Ratio Rank: 24
FXH Martin Ratio Rank: 25

IDNA

IDNA Risk / Return Rank: 55
IDNA Sharpe Ratio Rank: 48
IDNA Sortino Ratio Rank: 49
IDNA Omega Ratio Rank: 42
IDNA Calmar Ratio Rank: 76
IDNA Martin Ratio Rank: 61

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FXH vs. IDNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Health Care AlphaDEX Fund (FXH) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FXH	IDNA	Difference
Sharpe ratio: Return per unit of total volatility	0.85	1.68	-0.83
Sortino ratio: Return per unit of downside risk	1.34	2.44	-1.09
Omega ratio: Gain probability vs. loss probability	1.15	1.27	-0.12
Calmar ratio: Return relative to maximum drawdown	1.09	3.85	-2.76
Martin ratio: Return relative to average drawdown	3.33	10.98	-7.64
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FXH vs. IDNA - Sharpe Ratio Comparison

The current FXH Sharpe Ratio is 0.85, which is lower than the IDNA Sharpe Ratio of 1.68. The chart below compares the historical Sharpe Ratios of FXH and IDNA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	FXH	IDNA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.85	1.68	-0.83
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.03	-0.30	+0.33
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.38	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.51	0.10	+0.41

Drawdowns

FXH vs. IDNA - Drawdown Comparison

The maximum FXH drawdown since its inception was -43.70%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for FXH and IDNA.

Drawdown Indicators

	FXH	IDNA	Difference
Max Drawdown Largest peak-to-trough decline	-43.70%	-68.26%	+24.56%
Max Drawdown (1Y) Largest decline over 1 year	-12.20%	-10.66%	-1.54%
Max Drawdown (3Y) Largest decline over 3 years	-17.53%	-29.73%	+12.20%
Max Drawdown (5Y) Largest decline over 5 years	-29.49%	-68.26%	+38.77%
Max Drawdown (10Y) Largest decline over 10 years	-30.61%	—	—
Current Drawdown Current decline from peak	-9.07%	-45.61%	+36.54%
Average Drawdown Average peak-to-trough decline	-9.46%	-36.24%	+26.78%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.99%	3.73%	+0.26%

Volatility

FXH vs. IDNA - Volatility Comparison

The current volatility for First Trust Health Care AlphaDEX Fund (FXH) is 4.16%, while iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a volatility of 7.18%. This indicates that FXH experiences smaller price fluctuations and is considered to be less risky than IDNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FXH	IDNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.16%	7.18%	-3.02%
Volatility (6M) Calculated over the trailing 6-month period	11.17%	17.98%	-6.81%
Volatility (1Y) Calculated over the trailing 1-year period	15.75%	24.48%	-8.73%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.52%	28.42%	-11.90%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.47%	29.53%	-11.06%

FXH vs. IDNA - Expense Ratio Comparison

FXH has a 0.61% expense ratio, which is higher than IDNA's 0.47% expense ratio.

Dividends

FXH vs. IDNA - Dividend Comparison

FXH's dividend yield for the trailing twelve months is around 0.85%, less than IDNA's 1.07% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019
FXH First Trust Health Care AlphaDEX Fund	0.85%	0.75%	0.41%	0.24%	0.20%	0.00%	0.00%	0.00%
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund	1.07%	1.18%	0.98%	1.04%	0.54%	0.70%	0.26%	0.80%

Frequently Asked Questions

Can I hold both FXH and IDNA in my portfolio?

FXH and IDNA have a correlation of 0.68, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FXH or IDNA?

IDNA has higher volatility (7.18%) compared to FXH (4.16%). In terms of maximum drawdown, FXH dropped -43.70% vs IDNA's -68.26%.

Which ETF is better, FXH or IDNA?

On 5-year performance, FXH leads with 0.56% vs -8.42% for IDNA. On fees, IDNA is cheaper at 0.47% per year. On volatility, FXH has been the lower-risk option at 4.16%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, FXH or IDNA?

Over the 5-year period, FXH has performed better with a 0.56% return vs -8.42%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, FXH or IDNA?

IDNA is cheaper with a 0.47% expense ratio, compared with 0.61% for FXH.

Which ETF pays a higher dividend yield, FXH or IDNA?

IDNA has the higher dividend yield at 1.07%, compared with 0.85% for FXH.

What is the main difference between FXH and IDNA?

FXH tracks StrataQuant Health Care Index, while IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index. They also come from different issuers: First Trust and iShares. Their fees differ too: 0.61% for FXH and 0.47% for IDNA.

Which has better risk-adjusted returns?

IDNA currently has the higher Sharpe Ratio (1.68 vs 0.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.